Wednesday, November 09, 2016 3:37:06 AM
NanoLogix is pleased to announce the recent peer-reviewed research paper published in the Journal of Infectious Diseases in Obstetrics and Gynecology has been rated by AltMetric and Kudos, two services for tracking published research. In AltMetric, it was ranked as #1 out of 128 articles published in the above mentioned journal. In Kudos, the research paper was ranked in the top five percent of over 100,000 research outputs.
In addition, CEO Bret Barnhizer has been in meetings in Houston with both Drs. Sebastian and Jonathan Faro, along with investors, to plan and execute the next steps in the evolution of N-Assay studies, certifications, production, and marketing plans. The initial production has been and will be in Texas for the immediate future, during which time NanoLogix will be pursuing further plans to establish production in Ohio.
Good to know.
EI
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM